(Q37259057)
Statements
1 reference
Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology (English)
1 reference
Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
1 reference
D S Goodin
1 reference
B A Cohen
1 reference
P O'Connor
1 reference
L Kappos
1 reference
J C Stevens
1 reference
1 September 2008
1 reference
1 reference
71
1 reference
10
1 reference
766-773
1 reference
Identifiers
1 reference
1 reference